The British Journal of Dermatology (19thJune 2015 by JKL Tan and K Bhate et al) reported that acne is estimated to affect 9.4% of the global population, making it the 8th most prevalent disease worldwide. Epidemiological studies have demonstrated that acne is most common in pubescent teens, with boys most frequently affected, particularly with more sever forms of the disease”
A study of 92 private dermatology clinics found a 200% increase in the rise of adults seeking specialist acne treatment (The Telegraph 18.1.2016, The rise of adult acne is like an epidemic – India Sturgis reporting).
The Journal of Drugs in Dermatology (1stFebruary 2017, Tan J, Kang S, Leyden J et al) highlighted that “scarring is a known and bothersome companion to acne vulgaris”. Following their 1,972 patient analysis by 120 investigators, they found the incidence of acne scarring to be 43%”
Energist´s Nitrogen Plasma Skin Regeneration technology is clinically proven to induce a long term reduction in acne scar depth: 34% reduction at 10 days, 26% at 3 months and 23% at 6 months. Acne scar reduction is an FDA approved and CE marked treatment indication for Energist´s Nitrogen Plasma Skin Regeneration system.
Should you have troublesome acne scarring, please contact us to find out where your nearest Nitrogen Plasma Skin Regeneration system is being used and get your treatment booked with one of the trained experts.
Updated on: Tuesday, May 1st, 2018